Back to search
FDAFDA · Food and drugs·Recall number D-1409-2012

Metoprolol Tartrate Tablets USP 50 mg, 1000 count bottle, Rx only, Manufactured in india By: Emcure Pharmaceuticals LTD. Hinjwadi, Pune, India, Manufactured for TEVA Phamaceuticals USA, Sellersville, PA 18960, NDC 0093-0733-10

Published July 11, 2012 · Recall initiated: May 16, 2012

Summary

FDA records drug Class II recall D-1409-2012, published July 11, 2012 and initiated May 16, 2012. Recalling firm: Teva Pharmaceuticals USA, Inc.; Status: Terminated; Reported quantity: 2,268 bottles; Lot: Lot #TE1Y261, Exp, 12/2013. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Tablet Thickness: Potential for some tablets not conforming to weight specifications (under and over weight)

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teva Pharmaceuticals USA, Inc.
Distributor
Ohio
Lot
Lot #TE1Y261, Exp, 12/2013
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Metoprolol Tartrate Tablets USP 50 mg, 1000 count bottle, Rx only, Manufactured in india By: Emcure Pharmaceuticals LTD. Hinjwadi, Pune, India, Manufactured for TEVA Phamaceuticals USA, Sellersville, PA 18960, NDC 0093-0733-10 recalled?

Yes. FDA published recall D-1409-2012 on July 11, 2012. Reported hazard: Tablet Thickness: Potential for some tablets not conforming to weight specifications (under and over weight)

What should I do if I have this product?

Voluntary: Firm initiated · Letter